Use of propranolol in thyrotoxicosis.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002302:Cardiac Output; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000503:physiopathology; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011433:Propranolol